Tag: Screening

Only 22.3 percent of those with an initial LDCT had a repeat annual LDCT; 34.3 percent adherent with follow-up to 24 months

Screening for MDD recommended for teens aged 12 to 18 years; anxiety screening recommended for children aged 8 to 18 years

Substantial net benefit observed for screening of nonpregnant persons at increased risk for infection

Of all five U.S. Multi Society Task Force recommended tests, FIT-fecal DNA every three years was most preferred test

Sensitivities of rapid antigen tests with nasal self-sampling declined during period of omicron emergence

Anxiety screening recommended for adults aged 64 and younger, including pregnant, postpartum persons

Participants report feeling empowered by comprehensive screening

Specificity for MCED blood test using circulating tumor DNA is 99.1 percent, and positive predictive value is about 40 percent

Evidence insufficient for assessing benefits and harms of screening for children and adolescents

Quantitative segmentation algorithm used to extract data from hematoxylin and eosin slides of colorectal cancers